Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0001567619-20-019923

10% owner bought 476,667 shares at an average $4.76 ($2,270,484)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Logos Global Master Fund LP 10% owner 2020-11-09 Purchase +250,000 $1.10 $274,475 6,250,000 D: show line 1 in the form
Logos Global Master Fund LP 10% owner 2020-11-09 Purchase +100,000 $1.16 $116,410 6,350,000 D: show line 2 in the form
Logos Global Master Fund LP 10% owner 2020-11-13 Purchase +126,667 $14.84 $1,879,599 550,000 D: show line 3 in the form
Open-market purchases · 476,667 sh · avg $4.76 · $2,270,484
Loading xslF345X03/doc1.xml…